1167967

Beigene USA, Inc. — FEI 3014478572

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 8, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Mateo, CA (United States)

Additional Details

Sponsor, Contract Research Organization